IL1B and major depressive disorder: Notably, ZSQGY was able to reduce the levels of IL-1β, IL-6, TNF-α, and IFN-γ, which demonstrated the anti-inflammatory effects of ZSQGY in the central nervous system in the MSG-induced depression model.